|
Omnicell, Inc. (OMCL) Valoración de DCF
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Omnicell, Inc. (OMCL) Bundle
¿Busca determinar el valor intrínseco de Omnicell, Inc.? Nuestra calculadora DCF (OMCL) integra datos del mundo real con extensas características de personalización, lo que le permite refinar los pronósticos y mejorar sus opciones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 897.0 | 892.2 | 1,132.0 | 1,295.9 | 1,147.1 | 1,231.2 | 1,321.5 | 1,418.5 | 1,522.5 | 1,634.2 |
| Revenue Growth, % | 0 | -0.53722 | 26.88 | 14.48 | -11.48 | 7.33 | 7.33 | 7.33 | 7.33 | 7.33 |
| EBITDA | 78.4 | 107.1 | 174.4 | 96.8 | 60.7 | 120.5 | 129.3 | 138.8 | 148.9 | 159.9 |
| EBITDA, % | 8.73 | 12.01 | 15.41 | 7.47 | 5.29 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
| Depreciation | 64.1 | 71.6 | 84.9 | 99.2 | 95.6 | 95.2 | 102.2 | 109.7 | 117.7 | 126.3 |
| Depreciation, % | 7.15 | 8.02 | 7.5 | 7.65 | 8.33 | 7.73 | 7.73 | 7.73 | 7.73 | 7.73 |
| EBIT | 14.2 | 35.5 | 89.5 | -2.3 | -34.9 | 25.3 | 27.1 | 29.1 | 31.2 | 33.5 |
| EBIT, % | 1.59 | 3.98 | 7.91 | -0.17925 | -3.04 | 2.05 | 2.05 | 2.05 | 2.05 | 2.05 |
| Total Cash | 127.2 | 485.9 | 349.1 | 330.4 | 468.0 | 408.2 | 438.1 | 470.3 | 504.8 | 541.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 218.4 | 190.1 | 240.9 | 299.5 | 263.9 | 278.4 | 298.8 | 320.7 | 344.2 | 369.5 |
| Account Receivables, % | 24.34 | 21.31 | 21.28 | 23.11 | 23 | 22.61 | 22.61 | 22.61 | 22.61 | 22.61 |
| Inventories | 108.0 | 96.3 | 119.9 | 147.5 | 110.1 | 134.0 | 143.8 | 154.4 | 165.7 | 177.8 |
| Inventories, % | 12.04 | 10.79 | 10.59 | 11.39 | 9.6 | 10.88 | 10.88 | 10.88 | 10.88 | 10.88 |
| Accounts Payable | 46.4 | 40.3 | 71.5 | 63.4 | 45.0 | 61.1 | 65.6 | 70.4 | 75.6 | 81.1 |
| Accounts Payable, % | 5.17 | 4.52 | 6.32 | 4.89 | 3.93 | 4.96 | 4.96 | 4.96 | 4.96 | 4.96 |
| Capital Expenditure | -61.7 | -54.9 | -58.3 | -60.7 | -55.0 | -68.1 | -73.1 | -78.5 | -84.2 | -90.4 |
| Capital Expenditure, % | -6.87 | -6.15 | -5.15 | -4.69 | -4.8 | -5.53 | -5.53 | -5.53 | -5.53 | -5.53 |
| Tax Rate, % | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 |
| EBITAT | 11.8 | 39.0 | 105.6 | 5.3 | -35.3 | 19.3 | 20.8 | 22.3 | 23.9 | 25.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -265.7 | 89.6 | 89.0 | -50.5 | 59.9 | 24.2 | 24.1 | 25.8 | 27.7 | 29.8 |
| WACC, % | 7.21 | 7.39 | 7.39 | 6.34 | 7.39 | 7.14 | 7.14 | 7.14 | 7.14 | 7.14 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 106.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 31 | |||||||||
| Terminal Value | 984 | |||||||||
| Present Terminal Value | 697 | |||||||||
| Enterprise Value | 804 | |||||||||
| Net Debt | 146 | |||||||||
| Equity Value | 658 | |||||||||
| Diluted Shares Outstanding, MM | 45 | |||||||||
| Equity Value Per Share | 14.54 |
What You Will Receive
- Pre-Built Financial Model: Omnicell’s actual data facilitates accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other critical factors.
- Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
- Professional-Grade Template: An optimized Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Omnicell, Inc. (OMCL).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Omnicell, Inc. (OMCL).
- Visual Dashboard and Charts: Graphical representations highlight key valuation metrics for straightforward assessment.
How It Works
- Download the Template: Gain immediate access to the Excel-based OMCL DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
- Instant Calculations: The model automatically recalculates Omnicell's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Omnicell, Inc. (OMCL)?
- Accurate Data: Up-to-date Omnicell financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you from starting from scratch.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Intuitive design and guided instructions make it accessible for all users.
Who Should Use Omnicell, Inc. (OMCL)?
- Healthcare Providers: Streamline medication management and improve patient safety with advanced automation solutions.
- Pharmacy Managers: Enhance operational efficiency through integrated pharmacy management systems.
- Consultants: Tailor solutions for clients to optimize their medication distribution processes.
- Healthcare Administrators: Gain insights into improving workflow and reducing costs with data-driven analytics.
- Students and Educators: Utilize real-world applications of healthcare technology in academic settings.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Omnicell, Inc. (OMCL).
- Real-World Data: Omnicell’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Full annual and quarterly breakdowns for deeper insights into Omnicell’s performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Omnicell, Inc. (OMCL).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results focused on Omnicell’s metrics.